115 related articles for article (PubMed ID: 31339206)
1. Comparison of pre- and post-bronchodilator lung function as predictors of mortality: The HUNT Study.
Bhatta L; Leivseth L; Carslake D; Langhammer A; Mai XM; Chen Y; Henriksen AH; Brumpton BM
Respirology; 2020 Apr; 25(4):401-409. PubMed ID: 31339206
[TBL] [Abstract][Full Text] [Related]
2. Pre- and post-bronchodilator airway obstruction are associated with similar clinical characteristics but different prognosis - report from a population-based study.
Sawalha S; Hedman L; Rönmark E; Lundbäck B; Lindberg A
Int J Chron Obstruct Pulmon Dis; 2017; 12():1269-1277. PubMed ID: 28490870
[TBL] [Abstract][Full Text] [Related]
3. Effect of tiotropium on lung function decline in early-stage of chronic obstructive pulmonary disease patients: propensity score-matched analysis of real-world data.
Lee HY; Choi SM; Lee J; Park YS; Lee CH; Kim DK; Lee SM; Yoon HI; Yim JJ; Kim YW; Han SK; Yoo CG
Int J Chron Obstruct Pulmon Dis; 2015; 10():2185-92. PubMed ID: 26508848
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the fixed ratio and the
Oh DK; Baek S; Lee SW; Lee JS; Lee SD; Oh YM
Int J Chron Obstruct Pulmon Dis; 2018; 13():903-915. PubMed ID: 29559774
[TBL] [Abstract][Full Text] [Related]
5. Using post-bronchodilator FEV₁ is better than pre-bronchodilator FEV₁ in evaluation of COPD severity.
Chen CZ; Ou CY; Wang WL; Lee CH; Lin CC; Chang HY; Hsiue TR
COPD; 2012 Jun; 9(3):276-80. PubMed ID: 22360379
[TBL] [Abstract][Full Text] [Related]
6. Differences between absolute and predicted values of forced expiratory volumes to classify ventilatory impairment in chronic obstructive pulmonary disease.
Checkley W; Foreman MG; Bhatt SP; Dransfield MT; Han M; Hanania NA; Hansel NN; Regan EA; Wise RA;
Respir Med; 2016 Feb; 111():30-8. PubMed ID: 26712569
[TBL] [Abstract][Full Text] [Related]
7. A New Bronchodilator Response Grading Strategy Identifies Distinct Patient Populations.
Hansen JE; Dilektasli AG; Porszasz J; Stringer WW; Pak Y; Rossiter HB; Casaburi R
Ann Am Thorac Soc; 2019 Dec; 16(12):1504-1517. PubMed ID: 31404502
[No Abstract] [Full Text] [Related]
8. Pre- and post-bronchodilator lung function as predictors of mortality in the Lung Health Study.
Mannino DM; Diaz-Guzman E; Buist S
Respir Res; 2011 Oct; 12(1):136. PubMed ID: 21991942
[TBL] [Abstract][Full Text] [Related]
9. A novel CT-emphysema index/FEV
Loh LC; Ong CK; Koo HJ; Lee SM; Lee JS; Oh YM; Seo JB; Lee SD
Int J Chron Obstruct Pulmon Dis; 2018; 13():2543-2550. PubMed ID: 30174423
[TBL] [Abstract][Full Text] [Related]
10. Annual rates of change in pre- vs. post-bronchodilator FEV1 and FVC over 4 years in moderate to very severe COPD.
Tashkin DP; Li N; Halpin D; Kleerup E; Decramer M; Celli B; Elashoff R
Respir Med; 2013 Dec; 107(12):1904-11. PubMed ID: 23972968
[TBL] [Abstract][Full Text] [Related]
11. Area Under the Expiratory Flow-Volume Curve (AEX): Assessing Bronchodilator Responsiveness.
Ioachimescu OC; Stoller JK
Lung; 2020 Jun; 198(3):471-480. PubMed ID: 32211978
[TBL] [Abstract][Full Text] [Related]
12. Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Lung Function versus Monotherapies in GOLD Category A Patients with COPD: Pooled Data from the Phase III PINNACLE Studies.
Martinez FJ; Rabe KF; Lipworth BJ; Arora S; Jenkins M; Martin UJ; Reisner C
Int J Chron Obstruct Pulmon Dis; 2020; 15():99-106. PubMed ID: 32021148
[TBL] [Abstract][Full Text] [Related]
13. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
[No Abstract] [Full Text] [Related]
14. Tiotropium in Early-Stage Chronic Obstructive Pulmonary Disease.
Zhou Y; Zhong NS; Li X; Chen S; Zheng J; Zhao D; Yao W; Zhi R; Wei L; He B; Zhang X; Yang C; Li Y; Li F; Du J; Gui J; Hu B; Bai C; Huang P; Chen G; Xu Y; Wang C; Liang B; Li Y; Hu G; Tan H; Ye X; Ma X; Chen Y; Hu X; Tian J; Zhu X; Shi Z; Du X; Li M; Liu S; Yu R; Zhao J; Ma Q; Xie C; Li X; Chen T; Lin Y; Zeng L; Ye C; Ye W; Luo X; Zeng L; Yu S; Guan WJ; Ran P
N Engl J Med; 2017 Sep; 377(10):923-935. PubMed ID: 28877027
[TBL] [Abstract][Full Text] [Related]
15. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
[TBL] [Abstract][Full Text] [Related]
16. GOLD classifications and mortality in chronic obstructive pulmonary disease: the HUNT Study, Norway.
Leivseth L; Brumpton BM; Nilsen TI; Mai XM; Johnsen R; Langhammer A
Thorax; 2013 Oct; 68(10):914-21. PubMed ID: 23611880
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of the dual bronchodilator combination umeclidinium/vilanterol in COPD by age and airflow limitation severity: A pooled post hoc analysis of seven clinical trials.
Ray R; Tombs L; Naya I; Compton C; Lipson DA; Boucot I
Pulm Pharmacol Ther; 2019 Aug; 57():101802. PubMed ID: 31096036
[TBL] [Abstract][Full Text] [Related]
18. Assessment of bronchodilator response through changes in lung volumes in chronic airflow obstruction.
Figueroa-Casas JB; Diez AR; Rondelli MP; Figueroa-Casas MP; Figueroa-Casas JC
Medicina (B Aires); 2003; 63(5):377-82. PubMed ID: 14628645
[TBL] [Abstract][Full Text] [Related]
19. LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD.
Zhong N; Wang C; Zhou X; Zhang N; Humphries M; Wang L; Thach C; Patalano F; Banerji D;
Int J Chron Obstruct Pulmon Dis; 2015; 10():1015-26. PubMed ID: 26082625
[TBL] [Abstract][Full Text] [Related]
20. COPD exacerbations and patient-reported outcomes according to post-bronchodilator FEV
Chai CS; Ng DL; Bt Mos S; Ibrahim MAB; Tan SB; Pang YK; Liam CK
BMC Pulm Med; 2023 Apr; 23(1):150. PubMed ID: 37118725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
